Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016623 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Invigor Toric 1-Day Contact Lenses
A NA study of Astigmatism, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04016623: Completed NA study of Astigmatism, sponsored by CooperVision.
NCT04016623 is a NA study of Astigmatism that has completed, run by CooperVision. The registered enrollment target is 10 participants, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04016623, a NA study of Astigmatism, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
An evaluation of the clinical performance of the 1-day toric test contact lens compared to the 1-day toric control contact lens over one hour of lens wear.
Primary Outcome
Toric Mark visible or not visible. Data for all 4 pairs were combined and analyzed (n=40 contact lenses).
Conditions Studied
Interventions
- DEVICE 1-day toric test contact lens
- DEVICE 1-day toric control contact lens
Study Locations (1)
Indiana
- Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2019-06-04 |
| Phase | NA |
What the finished NCT04016623 record still lists
NCT04016623 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which 1-day toric test contact lens is the first listed.
NCT04016623 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04016623 about?
NCT04016623 is a clinical study titled "Clinical Evaluation of Invigor Toric 1-Day Contact Lenses". An evaluation of the clinical performance of the 1-day toric test contact lens compared to the 1-day toric control contact lens over one hour of lens wear.
What is the current status of trial NCT04016623?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-05-06. Estimated completion is 2019-06-04.
What conditions does trial NCT04016623 study?
This clinical trial studies the following conditions: Astigmatism.
What interventions are being tested in trial NCT04016623?
The interventions under investigation include: 1-day toric test contact lens (DEVICE), 1-day toric control contact lens (DEVICE).
Who is sponsoring clinical trial NCT04016623?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04016623 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04016623's enrollment target sits among peer trials
10 32nd of 31 the lowest of 31 other Astigmatism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Astigmatism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI